Chi‐Ling Chiang

Chi-Ling Chiang's research focuses on engineering nanoscale and biological delivery systems—such as extracellular vesicles (tiny cell-derived particles), lipid nanoparticles, and carbon nanotubes—for applications in gene therapy, vaccines, and cancer treatment. Work spans from basic mechanisms of how these carriers interact with cells and the body to translational applications like mRNA delivery for tissue repair and cancer immunotherapy. The research combines nanotechnology, molecular biology, and bioengineering techniques such as electroporation and gene delivery.

Publication output has grown from about 1 paper per year in 2017-2018 to a peak of 5-6 papers per year in 2022-2023, with a slight decline afterward but continued steady activity through 2025-2026.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026